AU2001241315A1 - Use of a composition - Google Patents
Use of a compositionInfo
- Publication number
- AU2001241315A1 AU2001241315A1 AU2001241315A AU4131501A AU2001241315A1 AU 2001241315 A1 AU2001241315 A1 AU 2001241315A1 AU 2001241315 A AU2001241315 A AU 2001241315A AU 4131501 A AU4131501 A AU 4131501A AU 2001241315 A1 AU2001241315 A1 AU 2001241315A1
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- extract
- leaves
- patient
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 abstract 5
- 230000037396 body weight Effects 0.000 abstract 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 abstract 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 244000131360 Morinda citrifolia Species 0.000 abstract 1
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract 1
- 229960004999 lycopene Drugs 0.000 abstract 1
- 235000012661 lycopene Nutrition 0.000 abstract 1
- 239000001751 lycopene Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0000698 | 2000-03-02 | ||
| SE0000698A SE516468C2 (sv) | 2000-03-02 | 2000-03-02 | Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus. |
| PCT/SE2001/000447 WO2001064231A1 (en) | 2000-03-02 | 2001-03-02 | Use of a composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001241315A1 true AU2001241315A1 (en) | 2001-09-12 |
Family
ID=20278673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001241315A Abandoned AU2001241315A1 (en) | 2000-03-02 | 2001-03-02 | Use of a composition |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1261358B1 (enExample) |
| AT (1) | ATE286402T1 (enExample) |
| AU (1) | AU2001241315A1 (enExample) |
| DE (1) | DE60108227D1 (enExample) |
| SE (1) | SE516468C2 (enExample) |
| WO (1) | WO2001064231A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
| US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
| US7244463B2 (en) | 2005-10-18 | 2007-07-17 | Tahitian Noni International, Inc. | Garcinia mangostana L. enhanced animal food product |
| US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
| US8790727B2 (en) | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
| US7442395B2 (en) | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
| US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
| US8025910B2 (en) | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
| EP4299059A1 (en) | 2022-07-01 | 2024-01-03 | Labelic Analysis, S.L. | Composition for the treatment of tinnitus |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409144A (en) * | 1978-01-19 | 1983-10-11 | Research Corporation Of The University Of Hawaii | Xeronine, a new alkaloid, useful in medical, food and industrial fields |
| US5288491A (en) * | 1992-09-24 | 1994-02-22 | Herbert Moniz | Noni (Morinda Citrifolia) as a pharmaceutical product |
-
2000
- 2000-03-02 SE SE0000698A patent/SE516468C2/sv not_active IP Right Cessation
-
2001
- 2001-03-02 AT AT01912627T patent/ATE286402T1/de not_active IP Right Cessation
- 2001-03-02 WO PCT/SE2001/000447 patent/WO2001064231A1/en not_active Ceased
- 2001-03-02 EP EP01912627A patent/EP1261358B1/en not_active Expired - Lifetime
- 2001-03-02 AU AU2001241315A patent/AU2001241315A1/en not_active Abandoned
- 2001-03-02 DE DE60108227T patent/DE60108227D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1261358A1 (en) | 2002-12-04 |
| DE60108227D1 (de) | 2005-02-10 |
| EP1261358B1 (en) | 2005-01-05 |
| SE0000698L (enExample) | 2001-09-03 |
| ATE286402T1 (de) | 2005-01-15 |
| SE0000698D0 (sv) | 2000-03-02 |
| WO2001064231A1 (en) | 2001-09-07 |
| SE516468C2 (sv) | 2002-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300889I2 (nl) | Trifluridine in combinatie met tipiracilhydrochloride | |
| WO2004112711A3 (en) | Oral extended-release composition | |
| RU2001122719A (ru) | Композиция для лечения от ожирения и способ эстетической терапии | |
| Singhal et al. | Probable benefits of green tea with genetic implications | |
| IL192137A (en) | Formulations useful in the treatment of male and female impotence | |
| EP1561464A3 (en) | Use of cyclopamine in the treatment of basal cell carcinoma and other tumors | |
| EP1259240B8 (en) | Agents, such as nicotinamide or cadpr for the treatment of skin disorders | |
| JPH09278663A (ja) | カイガンショウからの抽出物（ＰｙｃｎｏｇｅｎｏｌＴＭ） の経口投与によるヒト血小板の反応性の調節方法 | |
| SE0000698L (enExample) | ||
| JP2011513340A5 (enExample) | ||
| WO2006108692A3 (en) | Dosage form for oral administration of a vitamin | |
| WO2007018588A8 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
| CN101890102A (zh) | 野花椒根皮或茎皮提取物及其提取方法和口腔药用组合物 | |
| EP1778209B8 (en) | Methods and compositions for oral delivery of fts | |
| KR20010009465A (ko) | 금단증상을 억제하는 조성물 | |
| CA2396209A1 (en) | The use of mirtazapine for the treatment of sleep disorders | |
| WO2006138317A3 (en) | Dosage regimen for prasugrel | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| ATE261732T1 (de) | Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl | |
| WO2001054676A3 (de) | Formulierungen bei dehydratationszuständen | |
| UA91028C2 (ru) | Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса | |
| TW200626133A (en) | Oral medication for twice-daily administration | |
| GB0018322D0 (en) | Pharmaceutical compositions | |
| PL1668021T3 (pl) | Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie | |
| TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep |